Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, October 14 at 2:00 PM ET

Register Free →

Search

Top

QUEST DIAGNOSTICS MASSACHUSETTS LLC

Subsidiary ofQUEST DIAGNOSTICS INCORPORATEDUEI: FWMAGYPNMBB6CAGE: 80M19

QUEST DIAGNOSTICS MASSACHUSETTS LLC is a federal contractor, registered under UEI FWMAGYPNMBB6 and CAGE code 80M19. It has been awarded $10,035 in federal contracts. Primary work spans Biological Product (except Diagnostic) Manufacturing. Top awarding agencies include Department Of Health And Human Services.

Contact Information

Registration and classification details

Websitehttps://www.questdiagnostics.com

Address123 Main St, City, ST 12345

Registration

UEI Code

FWMAGYPNMBB6

CAGE Code

80M19

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

For Profit OrganizationLimited Liability Company

NAICS Codes

621511Medical Laboratories(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

Key Performance Metrics

Awards Count

1

All time

Active

0

Currently performing

Completed

1

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency

Department Of Health And Human Services$10.0K100%

Awards by NAICS

325414 - Biological Product (except Diagnostic) Manufacturing$10.0K100%

Awards by Agency Over Time

Awards by Place of Performance

Compete with QUEST DIAGNOSTICS MASSACHUSETTS LLC

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for QUEST DIAGNOSTICS MASSACHUSETTS LLC

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Join 750+ contractors already using CLEATUS

Open opportunities in QUEST DIAGNOSTICS MASSACHUSETTS LLC's top NAICS codes and agencies

Supply of Defibrinated Rabbit BloodThis subcontract involves the supply of defibrinated rabbit blood to prime contractors supporting projects for the Defense Health Agency within the Department of Defense. The scope of work includes the collection of rabbit blood, the defibrination process to meet specific requirements, and the bottling of the product into 50ml units. To ensure quality and traceability, the provider must generate lot numbers and product data sheets for every unit produced. The execution of this contract requires the use of biological processing equipment and laboratory-grade bottling facilities. The total deliverable consists of 48 units of defibrinated rabbit blood per period of performance, with the place of performance located in Silver Spring, Maryland. This opportunity falls under NAICS code 325414 and is associated with a response deadline of October 23, 2026.

Defense Health Agency (dha)

POSTED

DEADLINE

PANDHA-26-P-0000 046638 Defibrinated Rabbit Blood

Solicitation # PANDHA-26-P-0000_046638

The Defense Health Agency Contracting Activity, acting on behalf of the Walter Reed Army Institute of Research, intends to award a sole source contract to Lampire Biological Labs, Inc. under FAR 6.302 for the procurement of defibrinated rabbit blood. The requirement is categorized under NAICS code 325414 for Biological Product Manufacturing. The contract structure consists of a base year followed by four one-year option periods, with a delivery requirement of 48 units per period of performance, where each unit is defined as one 50ml bottle. The contractor must ensure each unit is provided with a lot number and an associated product data sheet. Strict packaging and shipping standards are required to prevent leaks, spillage, and damage, while maintaining a temperature range of 2 to 8 degrees Celsius upon arrival at the destination in Silver Spring, Maryland. This procurement is being handled as a presolicitation notice of intent to sole source, with a response deadline for capability statements set for October 23, 2026.

Defense Health Agency (dha)

POSTED

DEADLINE

JAPANESE ENCEPHALIT

Solicitation # SPE2DP-26-R-0001

The Defense Logistics Agency Troop Support is soliciting Japanese Encephalitis Virus Vaccine, Purified, Inactivated, Single-Dose Prefilled Syringes under solicitation SPE2DP-26-R-0001, with a sole source justification under FAR 6.302-1 due to the unique nature of the product and regulatory requirements. The acquisition will follow Part 12 procedures for commercial items, resulting in a firm-fixed-price, indefinite delivery, indefinite quantity contract with an 18-month base term. The minimum order is 277,760 units, with an estimated and maximum quantity of 277,760 and 394,240 units respectively. Vaccines must be FDA-approved prior to the solicitation’s closing date and must comply with MPID Number 5 dated July 23, 2024. All deliveries are FOB destination to DLA Distribution Susquehanna in New Cumberland, Pennsylvania, with a 120-day production lead time following issuance of each DD1155 delivery order. Inspection and acceptance occur at the delivery point, and the contractor is responsible for certification of conformity with all specifications including FDA regulations and labeling requirements. All packaging, marking, and labeling must adhere to strict government standards including MIL-STD-2073-1 for preservation, MIL-STD-129 for shipping labels, and MIL-STD-130 for item identification. Units must be marked with the NSN, CAGE code, part number, contract number, preservation method and date, and transaction control number, with commercial preservation denoted as “COMM’L” and military as “M” followed by the method and date. Intermediate and exterior containers require bar codes compliant with DoD logistics standards, and hazardous materials necessitate a Shipper’s Declaration for Dangerous Goods and Safety Data Sheets. Shelf life must include at least 12 months remaining at time of delivery for Type I items, with expiration and manufacture dates clearly marked. Each shipment must include a destination label addressed to DODAAC SV3100, and all documentation must be in English using durable, legible markings. The contract requires electronic submission via the DIBBS portal and prohibits paper solicitations. Contractors must maintain inspection records for three years post-delivery and comply with all applicable federal regulations including the Federal Food, Drug, and Cosmetic Act and 49 CFR for hazardous materials. No socioeconomic set-asides apply,

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

TEST KIT, BACTERIA DETE

Solicitation # SPE2DS-27-T-0248

Solicitation SPE2DS-27-T-0248, issued by the DLA Troop Support Medical Supply Chain, is for the procurement of one package of API 20 E bacteria determination test kits for Enterobacteriaceae and other Gram-negative rods, identified by NSN 6550-01-507-3726. Each package contains 25 units. This FDA-regulated device requires strict temperature control, needing refrigeration between 2 and 8 degrees Celsius. The contract mandates a high level of freshness, requiring that no more than three months elapse between the date of manufacture and the date of delivery to the government. The item has a non-extendable shelf life of 18 months. Delivery is required within 20 days after the order, with FOB, inspection, and acceptance all occurring at the destination, specifically the USNS Comfort. Packaging must be commercial and compliant with MIL-STD-2073-1E and Special Packaging Instructions MPWPN00001, with marking adhering to Medical Marking Standard No. 1. Contractors must utilize the Wide Area WorkFlow system for invoicing and payment. The solicitation incorporates various FAR and DFARS clauses, including requirements for safeguarding covered defense information and compliance with the Buy American Act.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

in about 10 hours

VAC to Finished Vaccine ConversionThis subcontract involves the conversion of Government-owned Vaccine Antigen Concentrate into final-use Foot and Mouth Disease vaccine doses for prime contractors supporting USDA APHIS projects. The scope of work includes formulating the concentrate into a usable vaccine, performing filling and packaging within cleanroom facilities, and conducting essential final potency and efficacy testing. The project is managed under the Department of Agriculture and will be performed in Ames, Iowa. To be eligible, the contractor must hold a USDA Veterinary Biological Product License. The solicitation was posted on October 1, 2026, with a response deadline of November 10, 2026, falling under NAICS code 325414.

Mrpbs Minneapolis Mn

POSTED

DEADLINE

FMD Vaccine Antigen Concentrate (VAC) ProductionThis subcontract for the Department of Agriculture involves the production of Foot and Mouth Disease Vaccine Antigen Concentrates for prime contractors on USDA APHIS projects. The scope of work includes the purification and concentration of VAC serials, which are produced by engineering Master Seed Viruses or utilizing field strains in accordance with 9 CFR Parts 113 and 114. To qualify, the provider must possess a USDA Veterinary Biological Product License and provide propagation cell line data approved by the Center for Veterinary Biologics. The final deliverables are purified and concentrated FMD VAC serials, with performance taking place in Ames, Iowa. The response deadline for this opportunity is November 10, 2026.

Mrpbs Minneapolis Mn

POSTED

DEADLINE

Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC)

Solicitation # 12639527R0001

Solicitation 12639527R0001 is a request for proposals issued by the USDA Animal and Plant Health Inspection Service (APHIS) for an Indefinite Delivery Indefinite Quantity (IDIQ) contract. The requirement covers the purchase, storage, and production of Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC), the conversion of Government-owned VAC into usable finished vaccines, and the direct purchase of finished vaccines. The contract has a ceiling price of 800 million dollars and a long-term performance horizon, featuring five one-year ordering periods starting approximately December 1, 2026, with conversion and delivery of finished vaccines extending through November 30, 2044. The scope of work requires the contractor to produce VAC capable of yielding at least 1.0 million doses and maintain these materials on their premises under strict quality control and temperature standards. Because live FMDV is a Tier 1 Select Agent, the contractor must hold a select agent authorization issued by CDC/APHIS. Finished vaccines must be packaged to maintain temperatures between 2 to 8 degrees Celsius for 24 hours and include electronic temperature monitors. Award will be based on the most advantageous offer considering technical capability, past performance from the last five years, and fair and reasonable pricing. Proposals must be submitted electronically to Stephen Tees by November 10, 2026, at 1700 CT, organized into four separate volumes.

Mrpbs Minneapolis Mn

POSTED

DEADLINE

Repatriation Case Management and Financial Support Services

Solicitation # 47QTCA25D007Q-7571MN26F80127

This special notice announces the transfer of a contract for Repatriation Case Management and Financial Support Services from the Department of the Interior to the Department of Health and Human Services. Originally awarded to Respones AI, LLC on September 24, 2025, as contract number 47QTCA25D007Q - 140D0425F1000, the agreement transitioned to the new contract number 47QTCA25D007Q - 7571MN26F80127 effective September 29, 2026. The transfer maintains all original terms and conditions, specifically preserving the ultimate contract value and the period of performance. This project is designated as a total small business set-aside under NAICS code 541519, with the place of performance located in Virginia.

Department Of Health And Human Services

POSTED

DEADLINE

MEDICAL PHARMACY EMERGENCY NON NSN ORDER

Solicitation # SPE2DP-26-R-0002

Solicitation SPE2DP-26-R-0002 is a federal request for a firm-fixed price, indefinite-delivery, indefinite-quantity contract to establish a source of supply for the Influenza Virus Vaccine, Southern Hemisphere 2027 Formula. The contract, issued by the Medical Supply Chain Pharmacy FSA for the Department of Defense, covers a twelve month term for quadrivalent or trivalent vaccines suitable for individuals aged six months and older. The required product consists of 0.5 ML doses provided in packages of ten syringes. All quantities must be delivered to the Defense Distribution Center in Susquehanna, Pennsylvania, by March 31, 2027, with delivery appointments coordinated through DLA Distribution Susquehanna. Proposals must be submitted exclusively via the DLA Internet Bid Board System by October 14, 2026. Evaluation is based on price and the ability to meet all solicitation terms, including the provision of FDA approval for manufacturers or a manufacturer's Letter of Commitment for dealers. The contractor is responsible for ensuring products comply with USP requirements and the Drug Supply Chain Security Act. Strict packaging and marking standards apply, specifically Medical Marking Standard No. 1D, with rigorous cold chain requirements for refrigerated items (2 to 8 degrees Celsius) and frozen items (-25 to -10 degrees Celsius), including the use of DLA-compatible temperature monitors. Invoicing and payment will be processed electronically through the Wide Area Workflow system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Biomedical Research and TestingThis subcontract for Biomedical Research and Testing is issued by the Defense Advanced Research Projects Agency under the U.S. Department of Defense. The project focuses on conducting human or animal use research for prime contractors involved in SBIR/STTR TRIAGE-X projects, requiring the use of IRB/IACUC certified facilities for bio-medical testing and clinical trial management. The primary objective is the delivery of comprehensive clinical trial data and bio-research findings. The opportunity is designated as a Total Small Business Set-Aside under the SBIR/STTR mandate for companies with fewer than 500 employees, falling under NAICS code 325414. Interested parties must submit their responses by October 21, 2026, following the posting date of September 23, 2026.

Defense Advanced Research Projects Agency

POSTED

DEADLINE

Medical Diagnostic Test Kit SupplyThe Defense Logistics Agency under the Department of Defense has issued a subcontract for the supply of 100 E. coli detection test kits. These diagnostic kits must strictly adhere to FDA regulations, specific shelf-life requirements, and Department of Defense medical packaging standards to ensure quality and viability. Classified under NAICS code 325414, this procurement focuses on the delivery of specialized medical diagnostic tools. The contract was posted on August 11, 2026, and is managed through the DLA's acquisition systems to support military medical readiness.

Defense Logistics Agency

POSTED

DEADLINE

Medical Supply Procurement – Petrolatum GauzeThis subcontract with the Defense Logistics Agency under the Department of Defense involves the manufacture or supply of 27 units of petrolatum gauze, identified by NSN 6510-01-112-6414. The procurement falls under NAICS code 325414 and requires all units to meet strict military medical standards. Key delivery requirements include a minimum shelf life of 36 months, with a mandate that the time elapsed from manufacture to delivery does not exceed five months. The contract was posted on August 10, 2026.

Defense Logistics Agency

POSTED

DEADLINE

Typhoid Vi Polysaccharide Vaccine SupplyThis subcontract through the Defense Logistics Agency under the Department of Defense involves the supply of 1,000 units of FDA-compliant, preserved Typhoid Vi Polysaccharide Vaccine. The procurement is categorized under NAICS code 325414 and is designated for delivery to a U.S. Navy vessel. The agreement is established under FOB Destination terms, ensuring the delivery of the medical supplies to the specified naval location. The contract was posted on August 10, 2026, and is managed via the DIBBS system.

Defense Logistics Agency

POSTED

DEADLINE

Supply and Delivery of Typhoid VI Polysaccharide Vaccine (NSN 6505015334962)This subcontract with the Defense Logistics Agency involves the procurement, packaging, and delivery of 1,000 units of preservative-free Typhoid VI Polysaccharide Vaccine. The product must comply with NDC 49281-0790-51 and NSN 6505015334962. The vaccines are to be delivered to the USS Theodore Roosevelt (CVN 71) at FPO AP 96632 by August 10, 2026. Shipping must be handled via FOB Destination using fast and traceable methods to ensure secure arrival.

Defense Logistics Agency

POSTED

DEADLINE

MMR Vaccine Supply and DeliveryThis subcontract, managed by the Defense Logistics Agency under the Department of Defense, involves the procurement and delivery of one unit of the Measles, Mumps, and Rubella (MMR) Virus Vaccine. The scope of work requires the provider to ensure compliant packaging and traceable shipping to guarantee the integrity of the medical supplies during transit. The final delivery is designated as FOB Destination to a U.S. Navy vessel currently deployed overseas. Classified under NAICS code 325414, the contract emphasizes strict adherence to delivery protocols to support military health operations in an international environment.

Defense Logistics Agency

POSTED

DEADLINE

Pharmaceutical Product Supply – Aluminum Hydroxide GelThis subcontract involves the supply and delivery of one unit of Aluminum Hydroxide Gel to a Defense Logistics Agency facility located in Suffolk, Virginia. The procurement is managed by the Department of Defense under NAICS code 325414, ensuring the product meets specific National Stock Number and National Drug Code requirements. The agreement focuses on the fulfillment of pharmaceutical product needs for the agency. All deliverables must be coordinated according to the specifications outlined for the designated delivery location in Virginia.

Defense Logistics Agency

POSTED

DEADLINE

Measles, Mumps, and Rubella (MMR) Vaccine Supply and DeliveryThe contract entails the supply and delivery of three units of Measles, Mumps, and Rubella vaccine to a U.S. Navy vessel at a forward operating base destination, with strict requirements for traceable express shipping and full compliance with established medical handling standards. The contractor is responsible for ensuring the vaccines remain viable throughout transit by adhering to temperature control, packaging, and documentation protocols mandated for biological materials. This is a subcontract under the Department of Defense, managed by the Defense Logistics Agency, with a NAICS code of 325414 indicating pharmaceutical preparation manufacturing. The delivery must be completed in accordance with military logistics guidelines, and all shipping records must maintain a verifiable chain of custody from origin to final receipt aboard the vessel. The contract was posted on August 9, 2026, and the place of performance is tied to a military operational location, though specific geographic details are not provided. The award reference number SPE2DX25D8022 and delivery identifier SPE2D926F8119 are linked to the official DLA procurement system, underscoring the mission-critical nature of timely and secure delivery. While the solicitation number is not listed, the subcontract structure suggests coordination with a prime contractor to fulfill the DOD’s medical readiness requirements. All activities must comply with federal regulations governing vaccine distribution and military supply chain integrity.

Defense Logistics Agency

POSTED

DEADLINE

Supply of Tetanus and Diphtheria Toxoids, Adsorbed VaccineThis subcontract, issued by the Defense Logistics Agency under the Department of Defense, involves the manufacture or supply of one unit of FDA-approved Tetanus and Diphtheria Toxoids, Adsorbed vaccine. The primary objective of the agreement is to ensure the delivery of this medical supply to a U.S. Navy vessel stationed at a foreign port. The contract is categorized under NAICS code 325414, which pertains to biological product manufacturing. It was posted on August 7, 2026, and is managed through the Defense Logistics Agency to support naval health requirements during overseas operations.

Defense Logistics Agency

POSTED

DEADLINE